MBOT Microbot Medical Inc.
Healthcare$1.81+5.85%ClosedMarket Cap: $82.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.55
P/S
742.15
EV/EBITDA
-4.76
DCF Value
$0.07
FCF Yield
-19.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
-9.5%
Operating Margin
-15278.1%
Net Margin
-13535.2%
ROE
-21.8%
ROA
-18.2%
ROIC
-21.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $105.0K | 1.9% | $-4.3M | $-3.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.1M | $-3.5M | $— | — |
| FY null | $0.00 | NaN% | $-14.7M | $-13.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.9M | $-3.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-3.7M | $-3.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.0M | $-2.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.4M | $-3.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-11.6M | $-11.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.3M | $-3.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.5M | $-2.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.4M | $-2.4M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.1M | $-3.2M | $-0.26 | — |